Diabetes and hypertensive vascular disease. Mechanisms and treatment.
D000496:Alloxan / Q000633:toxicity; D000804:Angiotensin II / Q000097:blood; D000818:Animals; D001810:Blood Volume; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000628:therapy; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003928:Diabetic Nephropathies / Q000150:complications / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D006977:Hypertension, Renal / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D007606:Juxtaglomerular Apparatus / Q000473:pathology; D009400:Nephrosclerosis / Q000209:etiology; D051381:Rats; D012083:Renin / Q000096:biosynthesis / Q000097:blood; D013564:Sympathetic Nervous System / Q000503:physiopathology
D000804:Angiotensin II; D000496:Alloxan; D012083:Renin